A New Therapy Keeps Cancer Care on Course When Low Platelets are an Obstacle
March 16, 2026
March 16, 2026
MIAMI, Florida, March 16 -- The University of Miami Miller School of Medicine posted the following news:
* * *
A New Therapy Keeps Cancer Care on Course When Low Platelets are an Obstacle
*
Summary
* A phase 3 study shows that romiplostim significantly reduces chemotherapy dose delays and reductions by stabilizing platelet counts in patients with gastrointestinal cancers.
* By addressing chemotherapy-induced thromb . . .
* * *
A New Therapy Keeps Cancer Care on Course When Low Platelets are an Obstacle
*
Summary
* A phase 3 study shows that romiplostim significantly reduces chemotherapy dose delays and reductions by stabilizing platelet counts in patients with gastrointestinal cancers.
* By addressing chemotherapy-induced thromb . . .